Yvon Bastard
Director Ejecutivo en HTL SAS .
Perfil
Yvon Bastard is currently the Chief Executive Officer at HTL SAS and the Chairman-Management Board & President at Horace Holding SAS.
He previously worked as a Director at Axyntis SAS.
Cargos activos de Yvon Bastard
| Empresas | Cargo | Inicio |
|---|---|---|
HTL SAS
 HTL SAS BiotechnologyHealth Technology HTL SAS manufactures and develops biological polymers for the pharmaceutical and medical fields. The firm’s products include Hyaluronan, Chrondroitin and Heparosan. The company was founded in 1992 and is headquartered in Javene, France. | Director Ejecutivo | - |
Horace Holding SAS
 Horace Holding SAS Investment ManagersFinance Horace Holding SAS provides fund management services. The company is based in Javene, France and has subsidiaries in France. The French company was founded in 2018. Yvon Bastard has been the CEO of the company since 2018. | Director Ejecutivo | 14/12/2018 |
Antiguos cargos conocidos de Yvon Bastard.
| Empresas | Cargo | Fin |
|---|---|---|
Axyntis SAS
 Axyntis SAS Chemicals: SpecialtyProcess Industries Axyntis SAS produces fine chemicals. It produces intermediates and active ingredients for the pharmaceutical, animal health, and agrochemical sectors. The company was founded in 2007 and is headquartered in Paris, France. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Axyntis SAS
Axyntis SAS Chemicals: SpecialtyProcess Industries Axyntis SAS produces fine chemicals. It produces intermediates and active ingredients for the pharmaceutical, animal health, and agrochemical sectors. The company was founded in 2007 and is headquartered in Paris, France. | Process Industries |
HTL SAS
HTL SAS BiotechnologyHealth Technology HTL SAS manufactures and develops biological polymers for the pharmaceutical and medical fields. The firm’s products include Hyaluronan, Chrondroitin and Heparosan. The company was founded in 1992 and is headquartered in Javene, France. | Health Technology |
Horace Holding SAS
Horace Holding SAS Investment ManagersFinance Horace Holding SAS provides fund management services. The company is based in Javene, France and has subsidiaries in France. The French company was founded in 2018. Yvon Bastard has been the CEO of the company since 2018. | Finance |
- Bolsa de valores
- Insiders
- Yvon Bastard
